Anaplasma phagocytophilum AptA modulates Erk1/2 signalling

40Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Anaplasma phagocytophilum causes human granulocytic anaplasmosis, one of the most common tick-borne diseases in North America. This unusual obligate intracellular pathogen selectively persists within polymorphonuclear leucocytes. In this study, using the yeast surrogate model we identified an A. phagocytophilum virulence protein, AptA (A. phagocytophilum toxin A), that activates mammalian Erk1/2 mitogen-activated protein kinase. This activation is important for A. phagocytophilum survival within human neutrophils. AptA interacts with the intermediate filament protein vimentin, which is essential for A. phagocytophilum-induced Erk1/2 activation and infection. A. phagocytophilum infection reorganizes vimentin around the bacterial inclusion, thereby contributing to intracellular survival. These observations reveal a major role for the bacterial protein, AptA, and the host protein, vimentin, in the activation of Erk1/2 during A. phagocytophilum infection. © 2010 Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Sukumaran, B., Mastronunzio, J. E., Narasimhan, S., Fankhauser, S., Uchil, P. D., Levy, R., … Fikrig, E. (2011). Anaplasma phagocytophilum AptA modulates Erk1/2 signalling. Cellular Microbiology, 13(1), 47–61. https://doi.org/10.1111/j.1462-5822.2010.01516.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free